Cancer Deaths Continue to Fall in EU, UK, Led by Ovarian Cancer
Mortality rates from most major cancers are predicted to continue falling in Europe and the UK in 2022, with a particularly striking reduction in deaths from ovarian cancer. Medscape Medical News
BRCA Testing Underused in Women With Ovarian Cancer
More than a decade after calls for universal screening for germline BRCA mutations in women with ovarian cancer, it remains underused. Medscape Medical News
Symptoms Common in High-Risk, Early-Stage Ovarian Cancer
"Even in early-stage disease, ovarian cancer is not necessarily a silent disease." Medscape Medical News
Fallopian Organoids Promising for Ovarian Cancer Prediction
Fallopian tube organoids hold the potential for predicting the development of ovarian cancer years in advance, researchers say. Reuters Health Information
FDA Approves Imaging Drug for Detecting Ovarian Cancer Lesions
The tumor-targeted agent pafolacianine causes ovarian cancer lesions to 'light up like stars against a night sky' and improve surgeons' ability to locate cancerous tissue. FDA Approvals
Maintenance Olaparib Benefits Sustained Beyond 2 Years Treatment
Women with newly diagnosed ovarian cancer and a BRCA mutation see sustained benefits in progression free survival rates after two years of maintenance olaparib therapy, a clinical trial analysis suggests. Reuters Health Information
Unexpected Thrombocytosis Could Flag Occult Cancer
Thrombocytosis that shows up in a routine blood test increases the risk for an imminent diagnosis of several typically 'silent' cancers, such as pancreatic, ovarian, and cervical cancers. Medscape Medical News
CNN’s Amanpour Being Treated for Ovarian Cancer
Christiane Amanpour, the chief international anchor for CNN, announced Monday at the start of her daily TV program that she's been diagnosed with ovarian cancer. WebMD Health News
Justices Reject Johnson & Johnson Appeal of $2B Talc Verdict
The Supreme Court is leaving in place a $2 billion verdict in favor of women who claim they developed ovarian cancer from using Johnson & Johnson talc products. Associated Press
Disappointment: Screening for Ovarian Cancer Does Not Cut Deaths
A huge British trial turned out negative: annual screening of healthy women for ovarian cancer did not reduce deaths from this aggressive cancer. Medscape Medical News
